In vivo characterization of inhibitory anti-PD-1 antibody superagonists

被引：0
|
作者：
Akkaya, B. [1 ,2 ]
Davis, S. J. [1 ,2 ]
Cornall, R. J. [1 ,2 ]
机构：
[1] Univ Oxford, Nuffield Dept Clin Med, Oxford, England
[2] Univ Oxford, MRC Human Immunol Unit, Oxford, England
来源：
IMMUNOLOGY | 2011年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [31] Telomelysin as an immunotherapy sensitizing gastrointestinal tumors to anti-PD-1 antibody
    Kanaya, Nobuhiko
    Kuroda, Shinji
    Kumon, Kento
    Kakiuchi, Yoshihiko
    Morihiro, Toshiaki
    Kubota, Tetsushi
    Kikuchi, Satoru
    Tazawa, Hiroshi
    Nishizaki, Masahiko
    Kagawa, Shunsuke
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2018, 109 : 222 - 222
  • [32] Anti-PD-1 Antibody Treatment Suppresses Endometriosis in a Murine Model
    Mamillapalli, Ramanaiah
    Habata, Shutaro
    Taylor, Hugh S.
    REPRODUCTIVE SCIENCES, 2022, 29 (SUPPL 1) : 202 - 202
  • [33] Development of a novel humanized mouse model for improved evaluation of in vivo anti-cancer effects of anti-PD-1 antibody
    Katano, Ikumi
    Hanazawa, Asami
    Otsuka, Iyo
    Yamaguchi, Takuya
    Mochizuki, Misa
    Kawai, Kenji
    Ito, Ryoji
    Goto, Motohito
    Kagawa, Takahiro
    Takahashi, Takeshi
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [34] Development of a novel humanized mouse model for improved evaluation of in vivo anti-cancer effects of anti-PD-1 antibody
    Ikumi Katano
    Asami Hanazawa
    Iyo Otsuka
    Takuya Yamaguchi
    Misa Mochizuki
    Kenji Kawai
    Ryoji Ito
    Motohito Goto
    Takahiro Kagawa
    Takeshi Takahashi
    Scientific Reports, 11
  • [35] Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody
    Murayama, Masakazu
    Hosonuma, Masahiro
    Kuramasu, Atsuo
    Kobayashi, Sei
    Sasaki, Akiko
    Baba, Yuta
    Narikawa, Yoichiro
    Toyoda, Hitoshi
    Isobe, Junya
    Funayama, Eiji
    Tajima, Kohei
    Sasaki, Aya
    Maruyama, Yuki
    Yamazaki, Yoshitaka
    Shida, Midori
    Hamada, Kazuyuki
    Hirasawa, Yuya
    Tsurui, Toshiaki
    Ariizumi, Hirotsugu
    Ishiguro, Tomoyuki
    Suzuki, Risako
    Ohkuma, Ryotaro
    Kubota, Yutaro
    Horiike, Atsushi
    Sambe, Takehiko
    Tsuji, Mayumi
    Wada, Satoshi
    Kobayashi, Shinichi
    Shimane, Toshikazu
    Tsunoda, Takuya
    Kobayashi, Hitome
    Kiuchi, Yuji
    Yoshimura, Kiyoshi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [36] Development of novel combination cancer immunotherapy using anti-PD-1 and anti-PD-L1 antibody
    Hasegawa, Hirotaka
    Sugiyama, Daisuke
    Kanda, Mitsuro
    Hayashi, Masamichi
    Tanaka, Chie
    Yamada, Suguru
    Nakayama, Goro
    Koike, Masahiko
    Nomoto, Shuji
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    Nishikawa, Hiroyoshi
    CANCER SCIENCE, 2021, 112 : 741 - 741
  • [37] Characterization of the LAG-3 targeting antibody BI 754111 in monotherapy and in combination with the anti-PD-1 antibody BI 754091
    Zettl, Markus
    Wurm, Melanie
    Schaaf, Otmar
    Tirapu, Inigo
    Mostbock, Sven
    Reschke, Markus
    Schmidbauer, Stephan-Michael
    Frego, Lee
    Lorenz, Ivo C.
    Thibodeau, Michael
    Blanset, Diann
    Cifuentes, Elisa Oquendo
    Moll, Juergen
    Kraut, Norbert
    Borges, Eric
    Vogt, Anne
    Sedgwick, Jonathon
    Waizenegger, Irene C.
    CANCER RESEARCH, 2018, 78 (13)
  • [38] Anti-PD-1 antibody scFv producing recombinant Bifidobacterium exerts antitumor effect in a larger fraction of the treated mice compared to full-length anti-PD-1 antibody
    Shioya, Koichiro
    Wang, Li
    Matsumura, Tomio
    Shimizu, Hitomi
    Kanari, Yasuyoshi
    Seki, Yuji
    Shimatani, Yuko
    Taniguchi, Shun'ichiro
    Kataoka, Shiro
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [39] A bridging assay for detection and characterization of anti-drug antibodies to dostarlimab, a new anti-PD-1 therapeutic monoclonal antibody
    Marilyn Patterson
    Lee Anne Beausang
    Bonita Rup
    Ronald R. Bowsher
    Kim Krug
    Murad Melhem
    Sharon Lu
    AAPS Open, 7 (1)
  • [40] Characterization of the Anti-PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice
    Burova, Elena
    Hermann, Aynur
    Waite, Janelle
    Potocky, Terra
    Lai, Venus
    Hong, Seongwon
    Liu, Matt
    Allbritton, Omaira
    Woodruff, Amy
    Wu, Qi
    D'Orvilliers, Amanda
    Garnova, Elena
    Rafique, Ashique
    Poueymirou, William
    Martin, Joel
    Huang, Tammy
    Skokos, Dimitris
    Kantrowitz, Joel
    Popke, Jon
    Mohrs, Markus
    MacDonald, Douglas
    Ioffe, Ella
    Olson, William
    Lowy, Israel
    Murphy, Andrew
    Thurston, Gavin
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (05) : 861 - 870
12345